Global Bone Cement and Glue Market is estimated to be valued at over USD 2.53 billion by 2033 and register a CAGR of over 5.6% during the forecast period 2025 to 2033.

Glue and bone cement are referred to as biomaterials that can be formulated by combining both the liquid phase and powder phase, which can be molded and shaped into a paste and then fixed once inserted into the body. They are extensively in a range of different applications of orthopedic surgery. When administered into the body, this enables minimally invasive surgical procedures. The two chief families of bone cements are those of the calcium phosphate cements and acrylic bone cements.

Factors that have propelled the growth of the bone cement and glue market include the rise in road accidents and sports-related injuries. Apart from this, the high expenditure and the compelling clinical data for introducing innovative bone cements, the shifts in novel biomaterials with high mechanical properties will most likely have negative effects on the market.

The growing presence of the geriatric population and bone disorders is one of the key factors that has played a crucial role in expanding the bone cement and glue market size, particularly in the European region. The augmentation of arthroplasty surgeries and the subsequent demand for newer bone glues would cement the market growth for bone glues. Bone glue is one such product that is required for minor fractures and is shown to be an advantageous supplement in the repairing of musculoskeletal tissue suture.

Having said that, there are stringent guidelines in the U.S in animal testing that are carried out for research purposes in universities and other such institutions. As a result, such regulations have made it mandatory to seek a license and registration with the U.S. Department of Agriculture and facilities. The annual inspections, carried out by the USDA’s Animal and Plant Health Inspection Service to regulate and sanction the use of animals, have had negative repercussions for the bone cement and glue market. Such stringent inspections have impeded the production of natural glue procured from animals. Substitutes that contain non-animal extracts are synthetic glues and are known to be more expensive, and can also cause issues related to compatibility. The skin irritation that is caused by the cement, extended application, the disintegration of the cement, which can result in the artificial joint coming off, are just some of the disadvantages of cemented arthroplasty and can pose potential threats to the market growth of the bone glue industry.

Global Bone Cement and Glue Market Segmentation:

By Type

  • Bone Cement
    • PMMA Cement
    • Calcium Phosphate Cement
    • Glass Polyalkenoate Cement
    • Non-Antibiotic Loaded Bone Cement
    • Antibiotic Loaded Bone Cement
  • Bone Glue
    • Natural Bone Glue
    • Synthetic Bone Glue

By Application

  • Arthroplasty
    • Total Knee Arthroplasty
    • Total Hip Arthroplasty
    • Total Shoulder Arthroplasty
  • Kyphoplasty
  • Vertebroplasty
  • Other Applications

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics/Physician Offices

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

North America, particularly the United States, remains the dominant demand center. Extensive orthopedic infrastructure, patient awareness, and high adoption rates for novel formulations sustain its leadership.

Europe continues to follow closely, supported by aging populations and rising public healthcare investment.

A particularly dynamic region is the Asia-Pacific, showing rapid market uptake driven by the increasing number of orthopedic centers, affordability, and deepening penetration in markets like China and India.

Noteworthy is the Indian orthopedic bone cement market, which segregates data by type and end-user, affirming its projected growth through 2029 and 2034

Major players included in the Bone Cement and Glue Market:

  • Smith and Gephew
  • Zimmer Biomet Cardinal Health
  • DJO Global
  • Heraeus Medical
  • Arthrex
  • CryoLife
  • DePuy Synthes
  • Teknimed
  • Exactech
  • Stryker
  • Triumph

Key Developments by Leading Companies

1. Heraeus Medical

  • August 2024: Launched COPAL G+V, a dual antibiotic-loaded PMMA bone cement containing gentamicin and vancomycin. It delivers broad-spectrum infection protection in high-risk orthopedic surgeries and improves postoperative outcomes.

2. Zimmer Biomet

  • March 2025: Introduced Tekcem 1G and Tekcem 3G antibiotic-loaded cements in India (manufactured by Teknimed). These are designed for use in primary/revision arthroplasties and post-trauma reconstructions, with gentamicin to reduce monomer shrinkage while improving infection control.

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide an exhaustive analysis on the Bone Cement Glue Market By Type, By Application, By End User and By Region
  • To provide comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America, the Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com